194 related articles for article (PubMed ID: 20122829)
61. The ever-expanding role of HIF in tumour and stromal biology.
LaGory EL; Giaccia AJ
Nat Cell Biol; 2016 Apr; 18(4):356-65. PubMed ID: 27027486
[TBL] [Abstract][Full Text] [Related]
62. HIF in vascular development and tumour angiogenesis.
Breier G; Licht AH; Nicolaus A; Klotzsche A; Wielockx B; Kirsnerova Z
Novartis Found Symp; 2007; 283():126-33; discussion 133-8, 238-41. PubMed ID: 18300418
[TBL] [Abstract][Full Text] [Related]
63. The Local HIF-2α/EPO Pathway in the Bone Marrow is Associated with Excessive Erythrocytosis and the Increase in Bone Marrow Microvessel Density in Chronic Mountain Sickness.
Su J; Li Z; Cui S; Ji L; Geng H; Chai K; Ma X; Bai Z; Yang Y; Wuren T; Ge RL; Rondina MT
High Alt Med Biol; 2015 Dec; 16(4):318-30. PubMed ID: 26625252
[TBL] [Abstract][Full Text] [Related]
64. Epo is relevant neither for microvascular formation nor for the new formation and maintenance of mice skeletal muscle fibres in both normoxia and hypoxia.
Hagström L; Agbulut O; El-Hasnaoui-Saadani R; Marchant D; Favret F; Richalet JP; Beaudry M; Launay T
J Biomed Biotechnol; 2010; 2010():137817. PubMed ID: 20414335
[TBL] [Abstract][Full Text] [Related]
65. HIF proteins connect the RB-E2F factors to angiogenesis.
Bakker WJ; Weijts BG; Westendorp B; de Bruin A
Transcription; 2013; 4(2):62-6. PubMed ID: 23412359
[TBL] [Abstract][Full Text] [Related]
66. Analysis of VEGF--a regulated gene expression in endothelial cells to identify genes linked to angiogenesis.
Rivera CG; Mellberg S; Claesson-Welsh L; Bader JS; Popel AS
PLoS One; 2011; 6(9):e24887. PubMed ID: 21931866
[TBL] [Abstract][Full Text] [Related]
67. Expression and functions of vasoactive substances regulated by hypoxia-inducible factor-1 in chronic hypoxemia.
Tipoe GL; Lau TY; Nanji AA; Fung ML
Cardiovasc Hematol Agents Med Chem; 2006 Jul; 4(3):199-218. PubMed ID: 16842206
[TBL] [Abstract][Full Text] [Related]
68. Recombinant human erythropoietin alpha modulates the effects of radiotherapy on colorectal cancer microvessels.
Ceelen W; Boterberg T; Smeets P; Van Damme N; Demetter P; Zwaenepoel O; Cesteleyn L; Houtmeyers P; Peeters M; Pattyn P
Br J Cancer; 2007 Mar; 96(5):692-700. PubMed ID: 17299396
[TBL] [Abstract][Full Text] [Related]
69. Hypoxia Inducible Factor Expression and Angiogenesis - Analysis in the Pituitary Gland and Patterns of Death.
Kouroupi M; Sivridis E; Papazoglou D; Koukourakis MI; Giatromanolaki A
In Vivo; 2018; 32(1):185-190. PubMed ID: 29275318
[TBL] [Abstract][Full Text] [Related]
70. Association between serum concentrations of hypoxia inducible factor responsive proteins and excessive erythrocytosis in high altitude Peru.
Painschab MS; Malpartida GE; Dávila-Roman VG; Gilman RH; Kolb TM; León-Velarde F; Miranda JJ; Checkley W
High Alt Med Biol; 2015 Mar; 16(1):26-33. PubMed ID: 25760230
[TBL] [Abstract][Full Text] [Related]
71. Activation of protease-activated receptor 2 induces VEGF independently of HIF-1.
Rasmussen JG; Riis SE; Frøbert O; Yang S; Kastrup J; Zachar V; Simonsen U; Fink T
PLoS One; 2012; 7(9):e46087. PubMed ID: 23049945
[TBL] [Abstract][Full Text] [Related]
72. Hypoxia inducible factors-mediated inhibition of cancer by GM-CSF: a mathematical model.
Chen D; Roda JM; Marsh CB; Eubank TD; Friedman A
Bull Math Biol; 2012 Nov; 74(11):2752-77. PubMed ID: 23073704
[TBL] [Abstract][Full Text] [Related]
73. [Selected, biochemical markers of hypoxia].
Kwasiborski PJ; Kowalczyk P; Mrówka P; Kwasiborski M; Cwetsch A; Przybylski J
Przegl Lek; 2012; 69(3):115-9. PubMed ID: 22764653
[TBL] [Abstract][Full Text] [Related]
74. Metabolism and therapeutic angiogenesis.
Carmeliet P; Baes M
N Engl J Med; 2008 Jun; 358(23):2511-2. PubMed ID: 18525050
[No Abstract] [Full Text] [Related]
75. Disease-associated increased HIF-1, alphavbeta3 integrin, and Flt-1 do not suffice to compensate the damage-inducing loss of blood vessels in inflammatory myopathies.
Konttinen YT; Mackiewicz Z; Povilenaite D; Sukura A; Hukkanen M; Virtanen I
Rheumatol Int; 2004 Nov; 24(6):333-9. PubMed ID: 13680145
[TBL] [Abstract][Full Text] [Related]
76. Hypoxia-inducible factor-1 as regulator of angiogenesis in rheumatoid arthritis - therapeutic implications.
Westra J; Molema G; Kallenberg CG
Curr Med Chem; 2010; 17(3):254-63. PubMed ID: 20214567
[TBL] [Abstract][Full Text] [Related]
77. Hypoxic upregulation of arginase II in human lung endothelial cells.
Krotova K; Patel JM; Block ER; Zharikov S
Am J Physiol Cell Physiol; 2010 Dec; 299(6):C1541-8. PubMed ID: 20861464
[TBL] [Abstract][Full Text] [Related]
78. Hypoxia inducible factor as a therapeutic target for atherosclerosis.
Jain T; Nikolopoulou EA; Xu Q; Qu A
Pharmacol Ther; 2018 Mar; 183():22-33. PubMed ID: 28942242
[TBL] [Abstract][Full Text] [Related]
79. HIF-1alpha/VEGF pathway mediates 1,3,6,8-tetrabromo-9 H-carbazole-induced angiogenesis: a potential vascular toxicity of an emerging contaminant.
Xu T; Hu X; Yang G; Liu Y; Zhang Q; Yu S; Chen G; Li Y; Sha R; Chen Y; Xie HQ; Guo TL; Xu L; Zhao B
J Hazard Mater; 2022 Jun; 432():128718. PubMed ID: 35338935
[TBL] [Abstract][Full Text] [Related]
80. Hypoxia-inducible factors in human pulmonary arterial hypertension: a link to the intrinsic myeloid abnormalities.
Farha S; Asosingh K; Xu W; Sharp J; George D; Comhair S; Park M; Tang WH; Loyd JE; Theil K; Tubbs R; Hsi E; Lichtin A; Erzurum SC
Blood; 2011 Mar; 117(13):3485-93. PubMed ID: 21258008
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
